This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Humana's (HUM) Medicare Business Aids, High Costs Persist
by Zacks Equity Research
Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.
Economic Worries Buoy Rate-Cut Hopes: 5 Winners
by Tirthankar Chakraborty
Worries about a probable economic downturn have increased this week, fueling rate-cut hopes. CME's Fedwatch indicator showed that almost 90.3% of investors are now expecting another rate cut.
Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag
by Zacks Equity Research
Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.
Molina (MOH) Stock Moves -0.22%: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $109.48, marking a -0.22% move from the previous day.
Universal Health (UHS) Up 27.6% YTD: Will the Rally Continue?
by Zacks Equity Research
Universal Health (UHS) is poised to grow over the long term on the back of strong contribution from its segments and accretive acquisitions.
Molina Healthcare Enters Oversold Territory
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Are Investors Undervaluing Molina (MOH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
UnitedHealth to Offer New Medicare Advantage Plan in Bay Area (Revised)
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Molina (MOH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $116.21, marking a +1.44% move from the previous day.
UnitedHealth to Offer Medicare Advantage Plan in Bay Area
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Cigna Expands Health Care Exchange Offerings to New Markets
by Zacks Equity Research
Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.
Here is How Wall Street Reacts to Fed's Easing Cycle
by Tirthankar Chakraborty
Since we are expecting "insurance cuts", where a slowdown are imminent but the economy isn't in a recession, the benchmark S&P 500 is still very much poised to come up with healthy gains in the near term.
Humana and Seniorlink to Serve Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) collaborates with Seniorlink to unveil Virtual Care Team pilot for offering its Medicare Advantage members an improved healthcare management.
Molina (MOH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $115.25, marking a -0.59% move from the previous day.
Strategic Acquisitions Aid Revenue Growth at Ensign Group
by Zacks Equity Research
Ensign Group's (ENSG) series of strategic buyouts aids its top line and the trend is expected to continue.
Why Should You Retain Centene (CNC) Stock in Your Portfolio?
by Zacks Equity Research
Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.
MEDNAX Teams Up With CENTA to Expand Services in Florida
by Zacks Equity Research
MEDNAX (MD) inks a partnership deal with CENTA to strengthen its profile of varied healthcare solutions in Florida.
Why Anthem (ANTM) is an Attractive Pick for Your Portfolio
by Zacks Equity Research
Riding high on strategic buyouts, partnerships and a strong revenue flow, Anthem (ANTM) holds potential to reap benefits for investors.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is Molina (MOH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Retain WellCare Health in Your Portfolio?
by Zacks Equity Research
Riding on increasing membership and inorganic growth strategies, WellCare Health (WCG) holds potential to reap benefits for investors. Besides, the company inks a merger deal with Centene in 2020.
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Banking on divestitures and buyouts along with restructuring plans, Community Health (CYH) holds potential to reap benefits for investors.
The Zacks Analyst Blog Highlights: Molina, NRG, Kinross Gold, Apple and Home Depot
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, NRG, Kinross Gold, Apple and Home Depot
Chances of Rate Cut Rise on Jobs Slowdown: Winners & Losers
by Tirthankar Chakraborty
With an overwhelming majority of observers seeing an imminent rate cut on August's soft employment report, certain sectors stand to gain, while some will suffer. Take a look -